Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
42.93
-0.56 (-1.29%)
At close: Nov 20, 2024, 4:00 PM
43.00
+0.07 (0.16%)
After-hours: Nov 20, 2024, 6:27 PM EST
Merus Market Cap
Merus has a market cap or net worth of $2.94 billion as of November 21, 2024. Its market cap has increased by 110.10% in one year.
Market Cap
2.94B
Enterprise Value
2.17B
1-Year Change
110.10%
Ranking
Category
Stock Price
$42.93
Market Cap Chart
Since May 19, 2016, Merus's market cap has increased from $143.00M to $2.94B, an increase of 1,955.35%. That is a compound annual growth rate of 42.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.94B | 85.12% |
| Dec 29, 2023 | 1.59B | 121.65% |
| Dec 30, 2022 | 716.30M | -41.96% |
| Dec 31, 2021 | 1.23B | 142.03% |
| Dec 31, 2020 | 509.90M | 55.03% |
| Dec 31, 2019 | 328.90M | 20.92% |
| Dec 31, 2018 | 272.00M | -12.85% |
| Dec 29, 2017 | 312.10M | 3.83% |
| Dec 30, 2016 | 300.60M | 110.21% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veracyte | 3.03B |
| Dyne Therapeutics | 3.02B |
| Bausch Health Companies | 3.01B |
| Inari Medical | 2.98B |
| Edgewise Therapeutics | 2.98B |
| Xenon Pharmaceuticals | 2.96B |
| Amedisys | 2.95B |
| Vera Therapeutics | 2.91B |